Sponsor Pipeline

Centre for Addiction and Mental Health Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
50
Active Trials
27
Recruiting
10
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT07146633
Efficacy of an EMDR App for PTSD and SUD
date change Primary completion moved earlier: 2027-12-31 -> 2027-01-30
2026-05-23 NCT07146633
Efficacy of an EMDR App for PTSD and SUD
date change Completion moved earlier: 2027-12-31 -> 2027-01-30
2026-05-19 NCT06299319
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for…
overall status: "Recruiting" → "Enrolling By Invitation"
Active Trials by Phase
Phase 4
5
Phase 2
5
Phase 1
3
Not specified
37
Active Trials — top 25 of 50
NCT IDTitleConditionStatus
Phase 4
NCT05515354 Smoking Cessation and Menstrual Cycle Phase Nicotine Dependence Recruiting
NCT06346028 Implementation of Transcranial Magnetic Stimulation for Smoking Cessation Smoking Recruiting
NCT05744479 Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability Intellectual Disability Recruiting
NCT07109245 Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect? Brain Insulin Sensitivity Recruiting
NCT04478838 "Extended" (Alternate Day) Antipsychotic Dosing Schizophrenia and Related Disorders Recruiting
Phase 2
NCT06512389 Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder Alcohol Use Disorder Recruiting
NCT06512220 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in… Treatment Resistant Depression Recruiting
NCT07405606 Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use… Major Depressive Disorder (MDD) Not Yet Recruiting
NCT06041152 Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment Amnestic Mild Cognitive Impairment Active, Not Recruiting
NCT07211438 Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant… Treatment-Resistant Depression Not Yet Recruiting
Phase 1
NCT06731621 Psilocybin for Treatment-Resistant Depression in Autism Treatment Resistant Depression Recruiting
NCT06299319 Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for… Obsessive-Compulsive Disorder Enrolling by Invitation
NCT03741478 Intranasal Insulin and Olanzapine Study in Healthy Volunteers Healthy Controls Active, Not Recruiting
Not specified
NCT06854367 Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression Late Life Depression (LLD) Recruiting
NCT06672588 Magnetic Seizure Therapy for Schizophrenia - Trial Treatment Resistant Schizophrenia Recruiting
NCT06086366 Presynaptic Imaging in Major Depressive Episodes After COVID-19 Long COVID Recruiting
NCT06780917 Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major… Mild Cognitive Impairment (MCI) Recruiting
NCT05526196 Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and… Driving Under the Influence Recruiting
NCT06373484 Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents Disruptive Behavior Disorder Recruiting
NCT06370988 Theta-Burst Stimulation for Bipolar Depression Bipolar Depression Recruiting
NCT04972136 rTMS for Depression in Young Adults With Autism Autism Spectrum Disorder Recruiting
NCT06885606 The Use of tDCS for Vaping Reduction Vaping Recruiting
NCT05855668 Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions… Alcohol Use Disorder Recruiting
NCT04325958 Age Differences in the Effects of Cannabis on Simulated Driving Cannabis Recruiting
NCT05142735 Effects of NAC on Symptoms of CHR Patients Prodromal Schizophrenia Recruiting
View all 50 active Centre for Addiction and Mental Health trials with filters →
Disease Areas
Get alerts when Centre for Addiction and Mental Health's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free